AMMF - THE CHOLANGIOCARCINOMA CHARITY
AMMF operates across the UK:1. Funding research into methods of earlier diagnosis, effective treatments, causes & cures for CCA2. Providing support to those diagnosed with CCA and their loved ones, through a website, dissemination of information, and patient support 3. Raising awareness regarding CCA via the annual AMMF CCA Conference, and participating with other organisations & initiatives
Financial health, per its FY2024 accounts
The accounts state that total funds increased to £1,016,427 (2023: £965,870), driven by a net incoming resource of £50,557. The charity holds unrestricted reserves of £935,831, which the trustees consider sufficient to fund current obligations and designated future grants. No material uncertainties regarding the charity's ability to continue as a going concern were identified.
What the accounts disclose
“The charity ensures that sufficient reserves are retained in an appropriate form to fund its current obligations. Where specific research projects have been secured, the trustees designate sufficient unrestricted reserves to cover the expected future grants payable over the term of the research project.” — page 10
Leadership, per the charity’s website
- Helen Morement — CEO
Funders the charity credits
- Canopies UK Ltd
Structured financials (annual return, FY ending 31/01/2025)
Trustees
- Noel Corrigan FORSchair
- Gillian Corrigan RN
- Harold Corrigan
- TOM MOREMENT
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/01/2025 | £1.0m | £821k |
| 31/01/2024 | £929k | £878k |
| 31/01/2023 | £1.0m | £700k |
Common questions
Is AMMF - THE CHOLANGIOCARCINOMA CHARITY financially healthy?
Per its FY2024 accounts: The accounts state that total funds increased to £1,016,427 (2023: £965,870), driven by a net incoming resource of £50,557. The charity holds unrestricted reserves of £935,831, which the trustees consider sufficient to fund current obligations and designated future grants. No material uncertainties regarding the charity's ability to continue as a going concern were identified. Its FY2024 accounts were independently examined.
Who funds AMMF - THE CHOLANGIOCARCINOMA CHARITY?
Funders whose own accounts filings name AMMF - THE CHOLANGIOCARCINOMA CHARITY as a grant recipient include SETCHIM CHARITABLE FUND, EXTRA MILE CHALLENGES.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| SETCHIM CHARITABLE FUND | FY2025 | £20k | |
| EXTRA MILE CHALLENGES | FY2024 | £520 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE REED FOUNDATION | 1 | — |
| WARRANT OFFICERS' & SERGEANTS' MESS SCHOOL OF ELECTRICAL & MECHANICAL ENGINEERS | 1 | — |
| THE MAURICE WOHL CHARITABLE FOUNDATION | 1 | £800k |
| THE CHARLES WOLFSON CHARITABLE TRUST | 1 | £425k |
| THE REGATTA FOUNDATION | 1 | £100k |
| THE ADRIAN SWIRE CHARITABLE TRUST | 1 | £100k |
| Blood Cancer UK Research | 1 | £87k |
| THE ERANDA ROTHSCHILD FOUNDATION | 1 | £70k |
Charities like this
- THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION
- FOLLICULAR LYMPHOMA FOUNDATION
- CHILDREN WITH CANCER UK
- Oracle Head and Neck Cancer UK Limited
- ORTHOPAEDIC RESEARCH UK
- NOTTINGHAM UNIVERSITY HOSPITALS CHARITY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| AMMF - THE CHOLANGIOCARCINOMA CHARITY | £1.0m | — | 0 | above | — | no doubt |
| THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION | £508k | — | 0 | above | — | no doubt |
| FOLLICULAR LYMPHOMA FOUNDATION | £2.4m | £80,001 - £90,000 | — | unclear | — | no doubt |
| CHILDREN WITH CANCER UK | £17.8m | £130,001 - £140,000 | — | unclear | 20.0% | no doubt |
| Oracle Head and Neck Cancer UK Limited | £648k | — | — | unclear | — | material uncertainty |
| ORTHOPAEDIC RESEARCH UK | £1.4m | — | — | unclear | — | no doubt |